Headline News

Two FDA committees overwhelmingly voted to strike down monitoring requirements under a Risk Evaluation and Mitigation Strategy, or REMS, program for clozapine, a medication for individuals with treatment-resistant schizophrenia.

BOSTON — Using virtual asthma coaching improved asthma control in poorly controlled patients, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ORLANDO — In this video from the AIMed24 Annual Meeting, Jennifer Luo Law discusses areas where AI may improve maternal health outcomes in the United States.

Patients with recessive dystrophic epidermolysis bullosa experienced a reduction in pain and itch with pregabalin treatment, according to small study.

ORLANDO — AdventHealth has developed novel AI tools intended to improve the lives of both patients and caregivers, according to a presentation at the AIMed24 Annual Meeting.

A telemedicine-based nutrition counselling program emphasizing a low-carbohydrate diet resulted in sustained diabetes remission over half a decade for some individuals with type 2 diabetes, results of an open-label study showed.

WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.

The U.S. Preventive Services Task Force released a draft recommendation encouraging physicians to screen for syphilis in people who are pregnant as early as possible.

ORLANDO — In this video from the AIMed24 Annual Meeting, Marissa Fayer discusses the use of novel AI imaging technology to assist radiologists in detecting breast cancer and cutting costs.

SAN DIEGO — Patients treated with once-monthly efimosfermin 300 mg achieved significant improvements in metabolic dysfunction-associated steatohepatitis resolution and fibrosis at 24 weeks, according to late-breaking data.